IGM Biosciences Inc. (IGMS)

NASDAQ: IGMS · Real-Time Price · USD

1.33

-0.05 (-3.97%)

At close: May 01, 2025, 3:59 PM

1.34

0.37%

Pre-market: May 02, 2025, 08:00 AM EDT

IGM Biosciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	2.68M	2.13M	1.07M	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	9.11M	8.28M	10.6M	7.72M	3.58M	2.33M	278K	161K
Gross Profit	-6.43M	-6.15M	-9.53M	-7.72M	-3.58M	-2.33M	-278K	-161K
Operating Income	-208.58M	-263.46M	-227.96M	-165.32M	-83.28M	-44.5M	-22.79M	-11.15M
Interest Income	12.79M	17.74M	7.04M	159K	1.93M	n/a	n/a	n/a
Pretax Income	-195.79M	-245.74M	-221.1M	-165.16M	-81.36M	-43.13M	-22.71M	-11.05M
Net Income	-195.79M	-246.42M	-214.25M	-160.68M	-80.33M	-42.54M	-22.71M	-11.05M
Selling & General & Admin	50.41M	50.07M	49.74M	38.3M	18.25M	9.24M	3.83M	2.51M
Research & Development	160.85M	215.52M	179.29M	127.03M	65.03M	35.26M	18.96M	8.64M
Other Expenses	n/a	n/a	-181K	159K	1.93M	1.36M	80K	93K
Operating Expenses	211.26M	265.59M	229.03M	165.32M	83.28M	44.5M	22.79M	11.15M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	211.26M	265.59M	229.03M	165.32M	83.28M	44.5M	22.79M	11.15M
Income Tax Expense	n/a	678K	-6.85M	-4.48M	-1.02M	-597K	80K	n/a
Shares Outstanding (Basic)	60.51M	52.31M	41.54M	33.48M	30.75M	9M	438.07K	437.94K
Shares Outstanding (Diluted)	60.51M	52.31M	41.54M	33.48M	30.75M	9M	438.07K	437.94K
EPS (Basic)	-3.24	-4.71	-5.16	-4.8	-2.61	-4.73	-51.84	-25.24
EPS (Diluted)	-3.24	-4.71	-5.16	-4.8	-2.61	-4.73	-51.84	-25.24
EBITDA	-199.47M	-253.36M	-221.88M	-157.44M	-77.78M	-40.8M	-22.51M	-10.99M
EBIT	-208.58M	-261.63M	-227.96M	-165.16M	-83.28M	-44.5M	-22.79M	-11.15M
Depreciation & Amortization	9.11M	8.28M	10.6M	7.72M	3.58M	2.33M	278K	161K